chr1-22084526-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001791.4(CDC42):​c.179-1913T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.765 in 150,804 control chromosomes in the GnomAD database, including 44,236 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 44236 hom., cov: 26)

Consequence

CDC42
NM_001791.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.938

Publications

8 publications found
Variant links:
Genes affected
CDC42 (HGNC:1736): (cell division cycle 42) The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]
CDC42 Gene-Disease associations (from GenCC):
  • macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.859 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001791.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDC42
NM_001791.4
MANE Select
c.179-1913T>G
intron
N/ANP_001782.1
CDC42
NM_001039802.2
c.179-1913T>G
intron
N/ANP_001034891.1
CDC42
NM_044472.3
c.179-1913T>G
intron
N/ANP_426359.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDC42
ENST00000656825.1
MANE Select
c.179-1913T>G
intron
N/AENSP00000499457.1
CDC42
ENST00000315554.15
TSL:1
c.179-1913T>G
intron
N/AENSP00000314458.8
CDC42
ENST00000344548.8
TSL:1
c.179-1913T>G
intron
N/AENSP00000341072.3

Frequencies

GnomAD3 genomes
AF:
0.765
AC:
115330
AN:
150686
Hom.:
44216
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.758
Gnomad AMI
AF:
0.614
Gnomad AMR
AF:
0.747
Gnomad ASJ
AF:
0.754
Gnomad EAS
AF:
0.878
Gnomad SAS
AF:
0.882
Gnomad FIN
AF:
0.729
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.766
Gnomad OTH
AF:
0.765
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.765
AC:
115389
AN:
150804
Hom.:
44236
Cov.:
26
AF XY:
0.766
AC XY:
56416
AN XY:
73642
show subpopulations
African (AFR)
AF:
0.757
AC:
31081
AN:
41034
American (AMR)
AF:
0.747
AC:
11321
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.754
AC:
2612
AN:
3462
East Asian (EAS)
AF:
0.878
AC:
4494
AN:
5118
South Asian (SAS)
AF:
0.881
AC:
4198
AN:
4764
European-Finnish (FIN)
AF:
0.729
AC:
7482
AN:
10266
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.766
AC:
51841
AN:
67716
Other (OTH)
AF:
0.767
AC:
1599
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1235
2470
3706
4941
6176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.681
Hom.:
1970
Bravo
AF:
0.765
Asia WGS
AF:
0.869
AC:
3013
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.56
DANN
Benign
0.34
PhyloP100
-0.94
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2473316; hg19: chr1-22411019; API